Direxion Daily S&P Biotech Bull 3x Shares Rating $60.54 -0.04 (-0.07%) As of 06/12/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.77Holdings in LABU have an aggregate rating of Moderate Buy based on 1,445 analyst ratings issued in the past year covering 124 companies (71.6% of the portfolio).LABU Aggregate Price Target$60.54High Prediction$60.54Average Prediction$60.54Low Prediction$60.54Holdings in LABU have an aggregate price target of $60.54 and a range of $60.54 to $60.54 covering 124 companies (71.6% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy52 Buy rating(s)Moderate Buy57 Moderate Buy rating(s)Hold15 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.38%ALNYAlnylam Pharmaceuticals$304.67+2.0%4.2848 of 5 stars2.77$319.58 4.9%26Positive NewsAnalyst Forecast2.31%EXASExact Sciences$54.01-3.0%4.6142 of 5 stars2.95$70.90 31.3%22Positive News2.14%NBIXNeurocrine Biosciences$125.01+0.7%4.8948 of 5 stars2.86$162.00 29.6%22Positive NewsAnalyst Revision2.07%NTRANatera$164.35-1.4%1.9316 of 5 stars3.00$184.63 12.3%15Positive NewsInsider Trade1.97%UTHRUnited Therapeutics$286.14+3.5%4.9936 of 5 stars2.69$393.08 37.4%13Positive NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume1.83%GILDGilead Sciences$112.05+2.5%4.8761 of 5 stars2.78$110.55 -1.3%27Trending NewsOptions VolumeAnalyst Revision1.82%INCYIncyte$69.22+0.5%4.5455 of 5 stars2.17$72.53 4.8%18Positive News1.79%INSMInsmed$96.88-1.1%3.3376 of 5 stars3.00$104.81 8.2%18Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume1.77%BPMCBlueprint Medicines$128.21+0.2%1.1806 of 5 stars2.32$129.35 0.9%22High Trading Volume1.76%BIIBBiogen$132.31-0.6%4.7014 of 5 stars2.38$188.19 42.2%32Trending NewsAnalyst Forecast1.75%AMGNAmgen$297.29+1.9%4.4732 of 5 stars2.38$309.22 4.0%24Positive NewsAnalyst Revision1.74%EXELExelixis$41.78+0.8%4.5366 of 5 stars2.47$39.76 -4.8%19Analyst Forecast1.69%VRTXVertex Pharmaceuticals$460.06+1.7%4.6549 of 5 stars2.57$515.04 12.0%30Positive NewsAnalyst Revision1.67%ABBVAbbVie$192.27+0.4%4.7164 of 5 stars2.81$211.29 9.9%27Trending NewsAnalyst ForecastAnalyst Revision1.45%MDGLMadrigal Pharmaceuticals$297.21+1.0%4.3487 of 5 stars2.89$420.63 41.5%9Positive NewsAnalyst Revision1.44%MRNAModerna$27.35-1.4%4.4681 of 5 stars2.04$46.61 70.4%231.35%REGNRegeneron Pharmaceuticals$521.84+0.6%4.9012 of 5 stars2.85$836.48 60.3%26Analyst Revision1.34%BMRNBioMarin Pharmaceutical$57.28+0.2%4.9492 of 5 stars2.74$93.45 63.2%23Positive NewsAnalyst Revision1.22%BBIOBridgeBio Pharma$39.65+1.5%4.5684 of 5 stars2.92$57.36 44.7%12Trending NewsInsider TradeAnalyst Revision1.13%RVMDRevolution Medicines$41.11+0.8%4.4546 of 5 stars3.00$67.08 63.2%12Positive News1.12%TGTXTG Therapeutics$37.37-2.5%2.9523 of 5 stars2.80$40.80 9.2%5Analyst Revision1.09%HALOHalozyme Therapeutics$54.54+1.3%4.9126 of 5 stars2.17$61.90 13.5%12Positive News1.04%IONSIonis Pharmaceuticals$35.62-1.6%4.4545 of 5 stars2.65$56.83 59.6%20Analyst Forecast0.96%ROIVRoivant Sciences$11.47+1.7%2.4073 of 5 stars3.00$17.50 52.6%40.93%CRSPCRISPR Therapeutics$41.28-0.6%3.3104 of 5 stars2.50$71.75 73.8%18Analyst Revision0.91%SWTXSpringWorks Therapeutics$46.76+0.0%1.6018 of 5 stars2.13$52.57 12.4%8Positive NewsHigh Trading Volume0.87%VKTXViking Therapeutics$28.58-1.3%4.4163 of 5 stars3.00$87.15 204.9%14News CoverageOptions VolumeAnalyst Revision0.81%ALKSAlkermes$30.78-1.3%4.713 of 5 stars2.77$38.85 26.2%13Insider Trade0.80%CYTKCytokinetics$33.20+0.3%4.3604 of 5 stars2.93$70.92 113.6%15Analyst Revision0.79%RNAAvidity Biosciences$32.14+0.4%2.1702 of 5 stars3.07$67.33 109.5%15Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.78%ADMAADMA Biologics$21.60-1.2%2.1881 of 5 stars3.25$24.25 12.3%4Insider TradeAnalyst Revision0.76%ACADACADIA Pharmaceuticals$21.74-2.5%3.2637 of 5 stars2.69$26.79 23.2%16Analyst Revision0.75%PCVXVaxcyte$34.46-2.8%3.1857 of 5 stars3.10$136.50 296.1%10Positive NewsAnalyst Revision0.74%SMMTSummit Therapeutics$20.16+3.0%2.9306 of 5 stars2.77$35.09 74.1%13Trending NewsAnalyst UpgradeAnalyst RevisionGap Up0.67%NUVLNuvalent$77.91+1.3%2.5787 of 5 stars2.90$115.50 48.2%10Positive News0.65%AKROAkero Therapeutics$53.56+1.1%3.7423 of 5 stars3.00$82.50 54.0%7Trending NewsInsider Trade0.64%ACLXArcellx$66.51+0.5%2.8249 of 5 stars3.07$111.33 67.4%14Positive NewsInsider TradeAnalyst Revision0.64%SRPTSarepta Therapeutics$37.31-1.3%4.7688 of 5 stars2.87$122.61 228.6%230.62%RYTMRhythm Pharmaceuticals$63.02-2.8%4.1928 of 5 stars3.00$76.62 21.6%13Insider Trade0.60%SLNOSoleno Therapeutics$80.20+1.3%4.7588 of 5 stars3.11$106.78 33.1%9Positive NewsAnalyst Revision0.57%SRRKScholar Rock$33.32+0.9%4.4117 of 5 stars3.14$42.67 28.1%7Positive News0.55%CRNXCrinetics Pharmaceuticals$32.17-0.5%3.5602 of 5 stars2.91$74.56 131.8%11Positive NewsAnalyst Revision0.54%APLSApellis Pharmaceuticals$19.26-0.1%4.7688 of 5 stars2.62$40.05 108.0%21Positive NewsAnalyst Revision0.54%ARWRArrowhead Pharmaceuticals$16.22-3.1%3.607 of 5 stars2.75$43.71 169.5%8Analyst Revision0.53%KRYSKrystal Biotech$140.33+0.5%4.7115 of 5 stars3.00$211.13 50.4%9Positive NewsAnalyst Revision0.53%AGIOAgios Pharmaceuticals$34.50+0.3%4.1296 of 5 stars2.71$58.60 69.9%7Analyst Revision0.53%RAREUltragenyx Pharmaceutical$39.29+4.7%4.358 of 5 stars2.92$88.77 125.9%13Analyst RevisionHigh Trading Volume0.52%VCYTVeracyte$26.69-4.4%4.0099 of 5 stars2.70$40.90 53.2%10Positive News0.51%TWSTTwist Bioscience$33.63-4.3%4.2313 of 5 stars2.70$50.40 49.9%100.49%PTCTPTC Therapeutics$50.98+0.3%4.3439 of 5 stars2.64$63.75 25.0%14Analyst Revision0.48%BCRXBioCryst Pharmaceuticals$10.40-2.0%4.4245 of 5 stars2.89$16.56 59.2%9Analyst Revision0.46%CPRXCatalyst Pharmaceuticals$24.29-4.4%4.7874 of 5 stars3.25$32.83 35.2%80.44%RXRXRecursion Pharmaceuticals$5.17-4.3%1.9416 of 5 stars2.33$7.60 47.0%6Gap Down0.42%IDYAIDEAYA Biosciences$22.28+1.6%4.0165 of 5 stars2.93$54.27 143.6%14Analyst Revision0.41%MIRMMirum Pharmaceuticals$49.02+1.2%3.2276 of 5 stars3.17$60.73 23.9%12Analyst Revision0.41%GRALGrail$41.92-4.4%0.4782 of 5 stars2.25$31.50 -24.9%40.38%CLDXCelldex Therapeutics$20.35-0.3%2.9075 of 5 stars2.90$53.90 164.9%10Positive NewsAnalyst RevisionHigh Trading Volume0.38%TVTXTravere Therapeutics$14.94+2.9%2.5344 of 5 stars2.87$32.14 115.1%15Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.37%ARQTArcutis Biotherapeutics$13.50-1.7%2.101 of 5 stars2.83$18.80 39.3%60.37%PTGXProtagonist Therapeutics$56.32+1.8%2.015 of 5 stars3.00$65.44 16.2%9Insider Trade0.36%NVAXNovavax$7.15+0.8%3.9034 of 5 stars2.43$19.00 165.7%7Trending News0.36%IMVTImmunovant$15.94-1.3%1.5812 of 5 stars2.90$38.33 140.5%10Positive NewsAnalyst Revision0.35%VCELVericel$42.48-3.8%2.6607 of 5 stars3.00$61.14 43.9%7Positive News0.33%BEAMBeam Therapeutics$17.44-2.5%3.2847 of 5 stars3.00$48.75 179.5%15Positive NewsAnalyst Revision0.32%SNDXSyndax Pharmaceuticals$10.67-2.1%3.0193 of 5 stars2.91$35.91 236.5%110.32%CGONCG Oncology$26.50+1.2%2.5376 of 5 stars3.00$58.22 119.7%11Positive NewsAnalyst Revision0.31%KYMRKymera Therapeutics$47.29-2.3%3.1823 of 5 stars3.00$59.82 26.5%180.31%DYNDyne Therapeutics$14.46-0.8%2.5483 of 5 stars3.00$44.93 210.7%15Positive NewsAnalyst Forecast0.31%BHVNBiohaven$15.59-0.6%3.0093 of 5 stars3.07$59.46 281.4%15Short Interest ↑Analyst RevisionHigh Trading Volume0.30%DNLIDenali Therapeutics$14.93-1.7%4.3529 of 5 stars3.06$33.71 125.8%17Positive NewsAnalyst Revision0.30%CDNACareDx$18.83-6.2%3.8161 of 5 stars2.67$30.33 61.1%6Positive News0.28%APGEApogee Therapeutics$41.86-1.4%2.1625 of 5 stars3.00$94.60 126.0%5Gap DownHigh Trading Volume0.28%DVAXDynavax Technologies$10.40+2.2%4.1782 of 5 stars2.50$24.00 130.8%40.28%IRONDisc Medicine$52.71+3.6%2.4155 of 5 stars3.09$96.70 83.5%11Positive NewsAnalyst ForecastAnalyst Revision0.28%VERAVera Therapeutics$22.52+1.9%2.9098 of 5 stars3.10$65.00 188.6%10Short Interest ↑Analyst Revision0.27%FOLDAmicus Therapeutics$6.17+0.5%4.106 of 5 stars2.70$16.22 162.9%100.26%VRDNViridian Therapeutics$15.67-2.6%1.8399 of 5 stars2.90$37.56 139.7%10Positive News0.25%ARDXArdelyx$3.72+0.5%3.9684 of 5 stars2.90$10.39 179.3%10Insider TradeAnalyst Revision0.24%ETNB89bio$9.62-4.2%2.5849 of 5 stars3.00$26.43 174.7%8News CoveragePositive NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.24%GERNGeron$1.56+1.3%3.3047 of 5 stars2.78$5.06 224.5%9Gap Down0.24%JANXJanux Therapeutics$25.56+0.4%2.4205 of 5 stars3.09$95.25 272.7%11Positive NewsAnalyst Revision0.22%NTLAIntellia Therapeutics$8.35-0.2%4.6084 of 5 stars2.67$34.95 318.6%21Analyst RevisionGap Down0.21%NRIXNurix Therapeutics$11.96-5.3%2.3114 of 5 stars2.83$30.18 152.3%180.21%QUREuniQure$15.99-1.4%2.131 of 5 stars2.91$37.82 136.5%11Analyst Revision0.20%PRAXPraxis Precision Medicines$45.03+1.0%2.6099 of 5 stars2.80$109.90 144.1%10Analyst Forecast0.19%MNKDMannKind$3.83-1.3%3.1263 of 5 stars3.29$10.33 169.8%7Insider TradeAnalyst Revision0.19%SPRYARS Pharmaceuticals$14.40+0.4%3.4164 of 5 stars3.17$31.00 115.3%6Positive NewsAnalyst Revision0.19%SYRESpyre Therapeutics$17.71-1.6%2.4041 of 5 stars3.25$53.40 201.5%8Positive News0.18%RCUSArcus Biosciences$9.37+3.2%2.568 of 5 stars2.90$24.13 157.5%10Options VolumeAnalyst RevisionHigh Trading Volume0.17%AVXLAnavex Life Sciences$8.22+0.2%3.9254 of 5 stars3.33$44.00 435.3%3Positive News0.16%COGTCogent Biosciences$7.22-0.6%2.5566 of 5 stars2.75$14.57 101.8%8Positive News0.16%IMNMImmunome$9.79+3.2%1.6645 of 5 stars3.00$23.33 138.3%6Positive News0.15%IBRXImmunityBio$3.19-1.5%2.3876 of 5 stars3.20$12.25 284.0%50.15%VIRVir Biotechnology$5.22-0.6%3.0379 of 5 stars2.86$32.86 529.4%7Positive News0.14%CAPRCapricor Therapeutics$13.94+6.1%2.3092 of 5 stars3.00$35.50 154.7%6Trending NewsAnalyst Revision0.14%ALTAltimmune$7.15+9.3%3.1193 of 5 stars3.00$20.20 182.5%7High Trading Volume0.14%KROSKeros Therapeutics$13.64-1.1%3.6591 of 5 stars2.50$30.56 124.0%14Analyst Downgrade0.13%DAWNDay One Biopharmaceuticals$6.69-0.9%1.6359 of 5 stars3.13$30.57 357.0%80.13%IOVAIovance Biotherapeutics$2.31+3.1%4.5275 of 5 stars2.50$13.30 475.8%12Trending News0.13%KURAKura Oncology$6.66-3.8%4.457 of 5 stars2.93$24.50 267.9%14Analyst Revision This page (NYSEARCA:LABU) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABU Stock Free LABU Stock Alerts